Insmed Inc. buy JPMorgan Chase & Co.
Start price
08.06.26
/
50%
€81.42
Target price
08.06.27
€155.21
Performance (%)
32.57%
Price
13.08.26
€109.82
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Insmed Inc. has seen massive gains of 32.57%. This prediction currently runs until 08.06.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 33.256% | 33.256% |
| iShares Core DAX® | 0.881% | 5.632% |
| iShares Nasdaq 100 | 2.390% | 1.571% |
| iShares Nikkei 225® | 4.269% | 2.521% |
| iShares S&P 500 | 1.171% | 2.545% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by JPMorgan Chase & Co. from $180.00 to $179.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat